- Home
- » Tags
- » Henri Termeer
Top View
- Biotechnology Report 2017: Beyond Borders
- January 15, 2006
- Ideas, Perspectives and Updates from the Massachusetts Life
- Halfway Through 10-Year, $1 Billion Investment, Report Finds Massachusetts Life Sciences Center Creating Jobs, Driving Cluster Growth
- Biographies of the Biotechnologists
- Career Imprints
- Celebrating Women and Girls in Science
- Novartis's Entresto Voyage: Hindsight Is 20/20
- SAC 2016 Celebration of Science Book
- Return of Organization Exempt from Income
- Top 50 Orphan Drug Thought-Leaders
- Return of Organization Exempt from Income
- Pharmaceutical R&D: Costs, Risks, and Rewards (Part 14 Of
- To Improve the Health of Humanity
- Conscience and Courage: How Visionary CEO Henri Termeer Built a Biotech Giant and Pioneered the Rare Disease Industry
- Program Agenda Directions to the Liberty Hotel and Parking Information 5:30 Pm Registration
- Health and Human Biology by Henri Termeer
- BWT 121415 X4.Indd
- The 37Th Golden Door Award Gala
- View Annual Report
- Genzyme's Ethical Dilemma
- The 7Th Annual Worldview Scorecard
- AVEO PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
- NEWSLETTER April 2009, Volume XIX, No
- 2008 Saving Lives, Saving Money
- In Re Genzyme Corp. Securities Litigation 09-CV-11267
- PPCO Twist System
- Conscience and Courage: How Visionary CEO Henri Termeer Built a Biotech Giant and Pioneered the Rare Disease Industry
- Moderna 2020 Annual Report | 3 a Letter from Our CEO JANUARY 4, 2021 Cambridge, Mass., USA
- Scientists, Engineers, and Leaders Who Participated Directly in the Report, Or Who Became Aware of the Report and Asked to Sign
- ISPE Boston News
- Xconomyawardsprogram.Pdf
- Rory Riggs and John Lewis, Et Al. V. Genzyme Corporation, Et Al. 03-CV